Is Nuvation Bio (NUVB) One of the Best American Penny Stocks to Buy?

Nuvation Bio Inc. (NYSE:NUVB) is one of the 12 Best American Penny Stocks to Buy Right Now. On November 4, Citizens increased its price target on Nuvation Bio Inc. (NYSE:NUVB) from $6 to $8 and kept its Market Outperform rating.

This decision came after the company reported Q3 results. Citizens highlighted that Nuvation Bio Inc. (NYSE:NUVB) successfully started 204 patients on IBTROZI (taletrectinib) in the third quarter of 2025. This launch is exceeding expectations and outpacing other recent ROS1 inhibitor launches.

Is Nuvation Bio (NUVB) One of the Best American Penny Stocks to Buy?

IBTROZI (taletrectinib) is Nuvation Bio Inc.’s (NYSE:NUVB) next-generation inhibitor for ROS1-positive non-small cell lung cancer. Updated data has demonstrated that IBTROZI (taletrectinib) is continuing to show unprecedented durability.

Because of IBTROZI’s (taletrectinib) impressive performance, Citizens has raised its short-term forecasts for Nuvation Bio Inc. (NYSE:NUVB).

Nuvation Bio Inc. (NYSE:NUVB) is a biopharmaceutical company focused on developing oncology therapeutics.

While we acknowledge the potential of NUVB as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than NUVB and that has a 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 Stocks Under $20 to Buy According to Analysts and 12 Best Performing Stocks in the Last 3 Months.

Disclosure: None. This article is originally published at Insider Monkey.